{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:36:18Z","timestamp":1773920178652,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine malignancy, typically presenting at an advanced stage with distant metastases. We report a unique case of a 49-year-old female with metastatic ACC in the liver who exhibited an abscopal effect following pulse electric field (PEF) ablation. The patient initially presented with hypertension, male-patterned hair loss, voice hoarseness, and weight gain and was subsequently diagnosed with a large left adrenal mass along with liver and pulmonary metastases. Following surgical interventions\u2014including left salpingo-oophorectomy, hepatic wedge resection, and left adrenalectomy\u2014and initial systemic treatment with doxorubicin, etoposide, and cisplatin-mitotane (EDP-M), disease progression prompted initiating therapy with pembrolizumab and mitotane. The patient then received Y90 treatment in the right lobe; however, imaging demonstrated viable metastatic disease in the left lobe, which prompted PEF treatment. The patient received PEF almost 7 months post-pembrolizumab and mitotane initiation. Remarkably, two months post-PEF treatment, PET\/CT imaging demonstrated complete resolution of three of the four untreated lesions, suggesting an abscopal response. This case adds to the limited literature on PEF ablation, highlighting its potential not only as a local control strategy but also as an adjunct to systemic immunotherapy in liver tumors. Further prospective studies incorporating immune profiling are warranted to elucidate the underlying mechanisms and long-term benefits of this approach.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1592656","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:48:14Z","timestamp":1773902894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response"],"prefix":"10.3389","volume":"17","author":[{"given":"Sandra","family":"Gad","sequence":"first","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]},{"name":"St. George\u2019s University","place":["Chapel Hill, Grenada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mohnasky","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Schrank","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan David","family":"Sorah","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Myhre","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahareh","family":"Gholami","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Afrasiabi","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Kokabi","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina at Chapel Hill","place":["Chapel Hill, NC, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12902-021-00787-6","article-title":"The epidemiology of primary and secondary adrenal Malignancies and associated adrenal insufficiency in hospitalised patients: an analysis of hospital admission data, NSW, Australia","volume":"21","author":"Lubomski","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.5540","article-title":"Adrenocortical carcinoma: the range of appearances on CT and MRI","volume":"196","author":"Bharwani","year":"2011","journal-title":"Am J Roentgenol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1157740","article-title":"Long-term partial response in a patient with liver metastasis of primary adrenocortical carcinoma with adjuvant mitotane plus transcatheter arterial chemoembolization and microwave ablation: a case report","volume":"13","author":"Deng","year":"2023","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2023.100759","article-title":"Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease, Cancer Treat","volume":"37","author":"Lib\u00e9","year":"2023","journal-title":"Res Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000683","article-title":"Evaluation of the prognostic role of liver metastases on patient outcomes: systematic review and meta-analysis","volume":"29","author":"Waninger","year":"2023","journal-title":"Cancer J Sudbury Mass"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12554","article-title":"Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives","volume":"12","author":"Chen","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.899722","article-title":"Effect of pulsed field ablation on solid tumor cells and microenvironment","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102300","article-title":"Thermal ablation for hepatic tumors in high-risk locations","volume":"48","author":"Ndhlovu","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101671","article-title":"Pulsed electric field (PEF) treatment of refractory vulvar melanoma concurrently treated with immune checkpoint blockade demonstrating an abscopal response: A case report","volume":"57","author":"Knight","year":"2025","journal-title":"Gynecol Oncol Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2024.08.003","article-title":"Technical feasibility and safety of image-guided biphasic monopolar pulsed electric field ablation of metastatic and primary Malignancies","volume":"35","author":"Kim","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217361","article-title":"Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors","volume":"609","author":"Arciga","year":"2025","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2174\/092986712800099811","article-title":"Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies","volume":"19","author":"Frey","year":"2012","journal-title":"Curr Med Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2023.02.003","article-title":"The abscopal effect in patients with cancer receiving immunotherapy","volume":"4","author":"Nelson","year":"2023","journal-title":"Med N Y N"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121672","article-title":"Inducing the abscopal effect in liver cancer treatment: the impact of microwave ablation power levels and PD-1 antibody therapy","volume":"16","author":"Liao","year":"2023","journal-title":"Pharm Basel Switz"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"A733","DOI":"10.1136\/jitc-2022-SITC2022.0702","article-title":"702 Tertiary lymphoid structures (TLS) observed in non-small cell lung cancer (NSCLC) tumors treated with pulsed electric fields","volume":"10","author":"Iding","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jvir.2023.11.021","article-title":"Pulsed electric field ablation versus radiofrequency thermal ablation in murine breast cancer models: anticancer immune stimulation, tumor response, and abscopal effects","volume":"35","author":"Pastori","year":"2024","journal-title":"J Vasc Interv Radiol JVIR"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0101","article-title":"Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model","volume":"7","author":"Narayanan","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040941","article-title":"Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: the brescia experience","volume":"12","author":"Lagan\u00e0","year":"2020","journal-title":"Cancers"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2024.10.033","article-title":"Limited effectiveness in early human clinical experience with pulsed electrical field ablation","volume":"36","author":"Rouhezamin","year":"2025","journal-title":"J Vasc Interv Radiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1592656\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:48:15Z","timestamp":1773902895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1592656\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2026.1592656"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1592656","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1592656"}}